5 Nov 2026, 15:55
Meetings & Governance—
Announcement history available from 1 August 2025
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Nov 2026, 15:55 | Addendum to Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004, 08005 | |
| 2 Nov 2026, 11:37 | Initial Director's Interest Notice - A. Chapman | Director Interests | — | 02008 | |
| 2 Nov 2026, 08:32 | IIQ signs EXO-OC validation agreement with Sonic Healthcare | Company Update | MS | 11001 | |
| 30 Oct 2026, 08:23 | Board Changes | Meetings & Governance | — | 08006, 12001 | |
| 29 Oct 2026, 08:40 | Quarterly Activities Report and Appendix 4C - September 2026 | Quarterly Reports | MS | 19001, 19006 | |
| 26 Oct 2026, 08:53 | INOVIQ receives $1.782m R&D Tax Incentive Refund | Periodic Reports | — | 03014, 12008 | |
| 23 Oct 2026, 14:31 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 23 Oct 2026, 08:19 | INOVIQ Announces Leadership Change | Company Administration | MS | 12019 | |
| 30 Sept 2026, 08:35 | EXO-OC Technical Review and Commercialisation Pathway | Company Update | MS | 11001 | |
| 17 Sept 2026, 08:40 | 2026 Annual Report | Financial Results | — | 03001, 03002, 03011, 03012, 03013, 03020 | |
| 27 Aug 2026, 09:00 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 27 Aug 2026, 08:59 | Appendix 4E and Preliminary Financial Report | Financial Results | MS | 03003, 03011, 03012, 03013, 03020 | |
| 7 Aug 2026, 07:59 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 15 July 2026, 16:41 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 14 July 2026, 09:49 | EXO-OC Study Outcome Investor Webinar Presentation | Presentations | MS | 03026 | |
| 13 July 2026, 09:01 | Quarterly Activities Report and Appendix 4C - June 2026 | Quarterly Reports | MS | 19004, 19009 | |
| 8 July 2026, 09:22 | Investor Briefing on EXO-OC Test and study outcome | Presentations | — | 14014 | |
| 1 July 2026, 09:10 | EXO-OC algorithm and clinical study update | Company Update | MS | 09014, 11001 | |
| 29 June 2026, 08:44 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 26 June 2026, 15:15 | Notification of cessation of securities - IIQ | Securities Administration | — | 06027 | |
| 25 June 2026, 08:46 | Positive CAR-exosome data in ovarian cancer | Company Update | MS | 11001 | |
| 17 June 2026, 16:47 | Response to ASX Price Query | ASX Query | MS | 17003 | |
| 26 May 2026, 08:36 | Change of Director's Interest Notice - Peter Gunzburg | Director Interests | — | 02009 | |
| 22 May 2026, 08:21 | Change of Director's Interest Notice - Peter Gunzburg | Director Interests | — | 02009 | |
| 19 May 2026, 08:13 | Change of Director's Interest Notice - Peter Gunzburg | Director Interests | — | 02009 | |
| 28 Apr 2026, 08:43 | Quarterly Activities Report and Appendix 4C - March 2026 | Quarterly Reports | MS | 19003, 19008 | |
| 2 Apr 2026, 08:18 | Change of Director's Interest Notice - Max Johnston | Director Interests | — | 02009 | |
| 30 Mar 2026, 08:21 | Change of Director's Interest Notice - Mary Harney | Director Interests | — | 02009 | |
| 13 Mar 2026, 08:30 | Change of Director's Interest Notice - Peter Gunzburg | Director Interests | — | 02009 | |
| 3 Mar 2026, 08:41 | Change of Director's Interest Notice - Peter Gunzburg | Director Interests | — | 02009 | |
| 23 Feb 2026, 08:58 | Change of Director's Interest Notice - Peter Gunzburg | Director Interests | — | 02009 | |
| 18 Feb 2026, 08:47 | Appendix 4D and FY26 Half Year Financial Report | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 29 Jan 2026, 09:05 | Quarterly Business Update and Appendix 4C - December 2025 | Quarterly Reports | MS | 19002, 19007 | |
| 16 Jan 2026, 14:26 | Notification regarding unquoted securities - IIQ | Securities Administration | — | 06021 | |
| 23 Dec 2025, 08:44 | New CSO appointment | Company Administration | — | 12008 | |
| 22 Dec 2025, 08:46 | Positive in vivo CAR-EV data in TNBC | Company Update | MS | 11001 | |
| 19 Dec 2025, 10:33 | Notification of cessation of securities - IIQ | Securities Administration | — | 06027 | |
| 19 Dec 2025, 10:28 | Final Director's Interest Notice | Director Interests | — | 02010 | |
| 18 Dec 2025, 10:07 | Chairman appointment | Company Administration | — | 12017 | |
| 27 Nov 2025, 15:44 | 2025 AGM Results of Meeting | Meetings & Governance | — | 08003 | |
| 27 Nov 2025, 13:52 | Planned Board Changes | Company Administration | — | 12017 | |
| 27 Nov 2025, 13:51 | 2025 AGM Presentation | Presentations | — | 03026, 15002 | |
| 5 Nov 2025, 09:45 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 4 Nov 2025, 09:13 | Application for quotation of securities - IIQ | Securities Administration | — | 06020 | |
| 3 Nov 2025, 11:46 | Completion of Share Purchase Plan | Capital Raising | — | 06017 | |
| 29 Oct 2025, 08:58 | Quarterly Business Update and Appendix 4C - September 2025 | Quarterly Reports | MS | 19001, 19006 | |
| 24 Oct 2025, 09:30 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08001, 08004 | |
| 21 Oct 2025, 08:46 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 20 Oct 2025, 09:28 | Initial Director's Interest Notice | Director Interests | — | 02008 | |
| 17 Oct 2025, 09:03 | Cleansing Notice | Securities Administration | — | 06018 |